Skip to main content
NKTR logo
NKTR
(NASDAQ)
Nektar Therapeutics
$74.19-- (--)
Loading... - Market loading

Nektar Therapeutics (NKTR) Stock Price & Financial Analysis

Nektar Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$73.64 - $75.63
52-Week High$109.00
52-Week Low$33.40
Open$74.67
Volume601.54K
Average Volume (3M)581.16K
Market Cap1.84B
Shares Outstanding24.74M
Price to Sales (P/S)32.99
Price to Book (P/B)3.18
EV/EBITDA-14.89
Revenue (TTM)55.63M
Net Income (TTM)-158.10M
Free Cash Flow (TTM)-203.94M
EPS (TTM)$-8.10
Profit Margin-284.18%
Operating Margin-224.08%
Return on Equity (ROE)-27.44%
Debt to Equity0.25
50-Day MA$71.66
200-Day MA$64.91
52-Week Change84.64%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Nektar Therapeutics

What is the current stock price for NKTR?

As of the latest trading session, NKTR stock trades at $74.19. The 52-week range is $33.40–$109.00, with a day range of $73.64–$75.63.

What is the P/E ratio for NKTR?

The P/E ratio (Price-to-Earnings) for NKTR is shown in the Key Statistics section. This valuation metric helps compare Nektar Therapeutics to industry peers.

Does NKTR pay dividends?

Nektar Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NKTR?

Based on 2 analysts, the consensus for NKTR is Buy.

What is the market cap of NKTR?

Nektar Therapeutics's market capitalization is $1.84B, classifying it as a small-cap company. Nektar Therapeutics operates in the Healthcare sector within the Biotechnology industry.